Physiomics Share Discussion Threads

[robinyou] 27/7/2020 09:25

Everybody.
DATAIT's a trading disaster.

DATAIT sold GDR in the mid twenties and crowed about making a small profit and only weeks later it more than 10 bagged to £3. And then he bought back in GDR again at over £2 and it's over 50% down now at 77p. He did the same with UKOG. Bought about 0.37p and now it's 0.16p. Over a 50% loss
He also sold PYC at just over 5p


Finally, he's lost tens upon tens upon tens of thousands on ICON.He bought nearly 20M of those at 0.4p+ more than 40 times today's price of 0.01p.

He's trapped in with huge losses on those 3.
ICON down today over 12%....Timberrrrrrrrrrrrrrrrrrrrrr

Hehehehe

[newtoaim] 27/7/2020 09:22

Well that bit of fun appears to be over share price soon shame

[sapper2476] 27/7/2020 09:08

Still looking for 20p here. Might take a while but I’ll sit and wait.

[thehitman1] 27/7/2020 08:48

I haven't added yet but just imagine when I do add, which could be anytime.

[hodhasharon] 27/7/2020 08:45

"your a failure"

heheheheh no wonder this country is in such a state. :-)

[datait] 27/7/2020 08:36

6p soon folks this is over valued.

[the stigologist] 27/7/2020 08:36

Amazing numbers ! $1billion up front

[bidmsa] 27/7/2020 08:31

Astra And Daiichi Enter Oncology Collaboration

[thehitman1] 26/7/2020 23:01

Stig, why 100p?, why not 200p?.

[the stigologist] 26/7/2020 22:35

100p+ target

Chart has all the hallmarks of an Exponential Moonshoot

We know PYC is capable of it

Moonshoots into 100s in 2009, 2011
Moonshoot to 30+ in 2007

[the stigologist] 25/7/2020 15:06

There are known unknowns (Trading Update, New Employee/s, New Large Pharma, Whole new cancer pathways validated, Clients raising money to expand/accelerate R&D etc etc,Personalised Oncology trials, regulatory approval, partnerships etc)

And unknown unknowns

[newtoaim] 25/7/2020 14:18

Stig why is pyc so far behind the curve at present. What other news could be coming apart from the pharma deal

[newtoaim] 25/7/2020 12:11

Ha ha Next week

[hodhasharon] 25/7/2020 10:09

Next already is big, I think their home section Is particularly impressive.

[newtoaim] 25/7/2020 09:37

Next could be big

[shearluc] 25/7/2020 07:59

No doubt Personalised Cancer Care is the way of the future, and Physiomics is should do well...certainly worth a lot more than their lowly 10p.

They could take a leaf out of Tempus' book and put out some slick, more 'accessible' promotional material

[the stigologist] 24/7/2020 20:42

This video has now clocked up 1500 views !

It really is a must watch for any Physiomics shareholders, newbies and prospective shareholders

Physiomics has all the elements in place to become a UK Tempus

Tempus is a $5bn 'startup' in the USA. Led by a very credible CEO/Founder. It has former FDA Governor Scott Gottlieb on the Board.

At some point I suspect Tempus or another huge US healthcare concern will look to partner or buy Physiomics and we will be talking a PYC share price in the multiples of 100p then IMO

This. Is. Personalised. Oncology.